Cargando…

Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union

INTRODUCTION: Medication errors can have serious consequences for patients. To prevent the occurrence of medication errors in clinical practice, safety concerns may be included in the risk management plan and subsequently be addressed with routine and/or additional risk minimisation measures. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoeve, Christina E., Francisca, Reynold D. C., Zomerdijk, Inge, Sturkenboom, Miriam C. J. M., Straus, Sabine M. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965336/ https://www.ncbi.nlm.nih.gov/pubmed/31617081 http://dx.doi.org/10.1007/s40264-019-00874-7

Ejemplares similares

Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe
por: Francisca, Reynold D. C., et al.
Publicado: (2020)

Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021
por: Essink, Sharon C. M., et al.
Publicado: (2023)

Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors
por: Hoeve, Christina E., et al.
Publicado: (2020)

The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
por: Cavaleri, Marco, et al.
Publicado: (2021)

Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders
por: Mulder, Jorn, et al.
Publicado: (2021)

Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2021)

The work of the European Union Reference Laboratory for Food Additives (EURL) and its support for the authorisation process of feed additives in the European Union: a review
por: von Holst, Christoph, et al.
Publicado: (2016)

Proposal for authorisation to derogate from the standard procurement framework applicable at CERN for projects partially funded by the European Union
Publicado: (2015)

Proposal for authorisation to derogate from the standard procurement framework applicable at CERN for projects partially funded by the European Union
Publicado: (2015)

Isotretinoin exposure during pregnancy: a population-based study in The Netherlands
por: Zomerdijk, Ingeborg M, et al.
Publicado: (2014)

Improving the Safety of Medicines in the European Union: From Signals to Action
por: Potts, Joanne, et al.
Publicado: (2019)

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project
por: de Bie, Sandra, et al.
Publicado: (2015)

The pre‐ and post‐authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation
por: Ghalandari, N., et al.
Publicado: (2020)

The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children
por: Kreeftmeijer-Vegter, Annemarie Rosan, et al.
Publicado: (2014)

Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder
por: Agyemang, Elaine, et al.
Publicado: (2017)

GANIL authorised
Publicado: (1975)

Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 2018
por: Sultana, Janet, et al.
Publicado: (2022)

EU postmarket surveillance plans for medical devices
por: Pane, Josep, et al.
Publicado: (2019)

Descriptive analysis of postmarket surveillance data for hip implants
por: Pane, Josep, et al.
Publicado: (2020)

European Union Standards for Tuberculosis Care
por: Migliori, G.B., et al.
Publicado: (2012)

Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?
por: Jaeger, Simon U, et al.
Publicado: (2022)

Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use
por: Santoro, Aniello, et al.
Publicado: (2020)

The European Health Union and the protection of public health in the European Union: Is the European Union prepared for future cross-border health threats?
por: Seitz, Claudia
Publicado: (2023)

Epidemiology of human West Nile virus infections in the European Union and European Union enlargement countries, 2010 to 2018
por: Young, Johanna J, et al.
Publicado: (2021)

Measuring health expectancy in the European Union
por: Santos, JV, et al.
Publicado: (2022)

A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
por: Regula, Jaroslaw, et al.
Publicado: (2020)

The European Union and the Regions /
Publicado: (1995)

Authorisation for work with electrical equipment
por: Balle, Christoph
Publicado: (2013)

National Association of Authorised Officers
por: Weston, W. H. A.
Publicado: (1952)

Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
por: Collignon, Olivier, et al.
Publicado: (2018)

Clinical Trial Authorisation: A Final Look Back to Better Appraise the New European Regulation
por: Vignot, Stéphane, et al.
Publicado: (2023)

Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project”
por: Willame, Corinne, et al.
Publicado: (2023)

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description
por: Brandi, Maria Luisa, et al.
Publicado: (2022)

Safety Training Course: Electrical Authorisation
por: Balle, Christoph
Publicado: (2014)

Guidance on the renewal of the authorisation of feed additives
por: Bampidis, Vasileios, et al.
Publicado: (2021)

Osteoporosis in the European Union: a compendium of country-specific reports
por: Svedbom, A., et al.
Publicado: (2013)

Report on the state of the European Union /
Publicado: (2005)

The government and politics of the European Union /
por: Nugent, Neill
Publicado: (1994)

Bluetongue Epidemiology in the European Union
por: Saegerman, Claude, et al.
Publicado: (2008)

Policy-making in the European Union
por: Wallace, Helen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2j70i3vld6f6l5ui8ck3hjd4f5